Advertisement
Singapore markets closed

  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     

  • Nikkei

    38,946.93
    -122.75 (-0.31%)
     

  • Hang Seng

    19,220.62
    -415.60 (-2.12%)
     

  • FTSE 100

    8,416.45
    -7.75 (-0.09%)
     

  • Bitcoin USD

    69,606.16
    +1,184.30 (+1.73%)
     

  • CMC Crypto 200

    1,519.19
    +30.65 (+2.06%)
     

  • S&P 500

    5,314.36
    +6.23 (+0.12%)
     

  • Dow

    39,839.07
    +32.30 (+0.08%)
     

  • Nasdaq

    16,806.93
    +12.05 (+0.07%)
     

  • Gold

    2,424.00
    -14.50 (-0.59%)
     

  • Crude Oil

    79.41
    -0.39 (-0.49%)
     

  • 10-Yr Bond

    4.4120
    -0.0250 (-0.56%)
     

  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     

  • Jakarta Composite Index

    7,186.04
    -80.65 (-1.11%)
     

  • PSE Index

    6,633.66
    -49.12 (-0.74%)
     

Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update

Alimera Sciences, Inc.
·2-min read
Alimera Sciences, Inc.
Alimera Sciences, Inc.

Conference Call to be held the same day at 9:00am Eastern Time

ATLANTA, April 30, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report first quarter financial results on May 14, 2024, prior to the market open.

Management will host a conference call at 9:00 AM ET on the same day, to review financial results and provide an update on corporate developments. Following management’s formal remarks there will be a question-and-answer session.

ADVERTISEMENT

Participants can register for the conference by navigating to
https://dpregister.com/sreg/10188147/fc37036c2f

Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.

The conference call will also be available through live webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=rPb7Xp5V and is also available through the company’s website.

A webcast replay of the call will be available approximately one hour after the end of the call through August 14, 2024. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (toll) or via an international dial-in number at: https://services.choruscall.com/ccforms/replay.html. Please use the following replay code 9720210. The telephonic replay will be available until May 28, 2024.

About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:

For investor inquiries:

Jules Abraham

Scott Gordon

for Alimera Sciences

for Alimera Sciences

917-885-7378

scottg@coreir.com

julesa@coreir.com